CXCL8 and infection: The evidence that the risk of infections is not increased by reparixin treatment supports a complex model of neutrophil recruitment during infection characterized by an early phase, mediated by short-lived signals, and by an amplification phase, which is mediated by signaling cascades through leukotriene-B4 and IL-8/CXCR1-2 pathway (66, 67).